Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Danaher Corporation (DHR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Danaher's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
248.31 +1.73    +0.70%
11:36:18 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 432,970
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 245.88 - 248.88
Danaher 248.31 +1.73 +0.70%

Danaher Corporation Company Profile

 
Get an in-depth profile of Danaher Corporation, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

63000

Equity Type

ORD

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians’ offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Contact Information

Address 2200 Pennsylvania Avenue, North West Suite 800 West
Washington, 20037-1701
United States
Phone 202 828 0850
Fax 202 828 0860

Top Executives

Name Age Since Title
Mitchell P. Rales 66 1983 Co-Founder & Director
Rainer M. Blair 59 2014 President, CEO & Director
Raymond C. Stevens 59 2017 Independent Director
Elias Adam Zerhouni 72 2009 Independent Director
Alan G. Spoon 72 1999 Independent Director
Pardis C. Sabeti 47 2019 Director
Steven M. Rales 72 1983 Co-Founder & Chairman
Walter G. Lohr 79 1983 Independent Director
Teri L. List-Stoll 60 2011 Independent Director
A. Shane Sanders 59 2021 Independent Director
Linda Hefner Filler 63 2005 Lead Independent Director
John T. Schwieters 83 2003 Independent Director
James J. Collins 57 2021 Member of Scientific Advisory Board
David L. Rimm - 2021 Member of Scientific Advisory Board
Robert M. Hershberg 61 - Member of Scientific Advisory Board
Carl H. June 69 2022 Member of the Scientific Advisory Board
Phillip A. Sharp 78 2021 Member of Scientific Advisory Board
Feroz Dewan 47 2022 Independent Director
Sangeeta N. Bhatia 54 2022 Member of Scientific Advisory Board
Angela M. Caliendo - 2021 Member of Scientific Advisory Board
Jessica L. Mega 48 2019 Independent Director
David R. Walt 70 2021 Member of Scientific Advisory Board
Thomas Christian Sudhof 69 2021 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DHR Comments

Write your thoughts about Danaher Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jeff Bailey
JeffB Apr 23, 2024 9:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DHR $236.08 (Earnings)
alan alan
alan alan Jan 30, 2024 7:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2 years falling
Jeff Bailey
JeffB Oct 27, 2023 5:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DHR $187.88 -2.99% @ Friday Close!
Patrick Philippe
PaTT_Philippe Oct 26, 2023 9:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If you're long Danaher, it's time to get out and wait for a better entry. That's a top.
Jeff Bailey
JeffB Oct 26, 2023 9:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$220
Jeff Bailey
JeffB Oct 26, 2023 9:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$229.28
FRAZER1903
FRAZER1903 Oct 03, 2023 4:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
WTF is going on
FRAZER1903
FRAZER1903 Sep 01, 2023 1:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going to 280$?
Jeff Bailey
JeffB Aug 30, 2023 2:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DHR $264.10 +0.99% @ Close!
Jeff Bailey
JeffB May 24, 2023 5:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DHR $227.71 -1.00% @ Close!
Satyajit Gupta
Satyajit Gupta Apr 25, 2023 11:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
6% down 🙄
no name
no name Apr 25, 2023 7:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
where now is the fair value?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email